On Cancer

and/or

63 Blog posts found

Perspective

MSK’s Vision to Transform Lymphoma Treatment

Anas Younes, Chief of the Lymphoma Service, details MSK’s ambitious strategy for advancing lymphoma therapies.

Anas Younes, Chief of the Lymphoma Service at MSK

In the Clinic

The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers

A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.

MSK medical oncologist Luis Diaz, Jr.

In the News

#ASCO17: Post-Conference Roundup of Themes and Trends

Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.

American Society of Clinical Oncology logo

Q&A

Q & A: MSK Leads the Way in Treating Head and Neck Cancers

Learn how MSK specialists treat head and neck cancers using the most innovative approaches.

Doctor in green surgical scrubs wearing glasses and cap looking at camera.

Finding

Blood Will Tell: Scientists Find Clues to Immunotherapy Responders and Non-Responders

Why do some patients respond to immunotherapy while others do not? Blood may hold the answer.

photo of blood vials

Finding

#AACR17: Researchers Shed Light on Biological Activity of a New, First-in-Class Immunotherapy

A team at MSK uncovered how TRX518, a new immunotherapy drug in early development, works in the body.

Grey T lymphocytes

Finding

#AACR17: New Data Show Some Patients with Melanoma Live Longer When Receiving Immunotherapy Combination

For some patients with metastatic melanoma, a combination of two immunotherapies works better than either drug alone.

Finding

#AACR17: Study Explores Best Time to Give CAR T Cell Therapy

Leukemia patients may do better on CAR T cell therapy when they are treated early, before their disease relapses.

immune cells

In the Lab

CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level

What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.

CAR T cells attacking cancer

Feature

T Is for T Cell: The Science Behind Immunotherapy

By deciphering the biology of T cells, MSK scientists gave immunotherapy a boost.

T cells on the loose.